MY8600271A - Novel mercaptoimidazole derivatives process for their preparation, mercapto-imidazole derivatives for the treatment of inflammatory disorders, and pharmaceutical products containing them - Google Patents
Novel mercaptoimidazole derivatives process for their preparation, mercapto-imidazole derivatives for the treatment of inflammatory disorders, and pharmaceutical products containing themInfo
- Publication number
- MY8600271A MY8600271A MY271/86A MY8600271A MY8600271A MY 8600271 A MY8600271 A MY 8600271A MY 271/86 A MY271/86 A MY 271/86A MY 8600271 A MY8600271 A MY 8600271A MY 8600271 A MY8600271 A MY 8600271A
- Authority
- MY
- Malaysia
- Prior art keywords
- derivatives
- mercapto
- novel
- preparation
- treatment
- Prior art date
Links
- OXFSTTJBVAAALW-UHFFFAOYSA-N 1,3-dihydroimidazole-2-thione Chemical class SC1=NC=CN1 OXFSTTJBVAAALW-UHFFFAOYSA-N 0.000 title 2
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229940127557 pharmaceutical product Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU79412 | 1978-04-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY8600271A true MY8600271A (en) | 1986-12-31 |
Family
ID=19728887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MY271/86A MY8600271A (en) | 1978-04-11 | 1986-12-30 | Novel mercaptoimidazole derivatives process for their preparation, mercapto-imidazole derivatives for the treatment of inflammatory disorders, and pharmaceutical products containing them |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US4461770A (cs) |
| EP (1) | EP0004648B1 (cs) |
| JP (1) | JPS54135769A (cs) |
| KR (2) | KR820002314B1 (cs) |
| AT (1) | AT376971B (cs) |
| AU (1) | AU532402B2 (cs) |
| CS (1) | CS220324B2 (cs) |
| CY (1) | CY1302A (cs) |
| DD (1) | DD142712A5 (cs) |
| DE (1) | DE2963572D1 (cs) |
| DK (1) | DK148879A (cs) |
| ES (5) | ES479490A0 (cs) |
| FI (1) | FI65066C (cs) |
| GR (1) | GR71193B (cs) |
| HK (1) | HK87285A (cs) |
| HU (1) | HU182018B (cs) |
| IL (1) | IL57040A (cs) |
| MY (1) | MY8600271A (cs) |
| NO (1) | NO148926C (cs) |
| NZ (1) | NZ190153A (cs) |
| PL (2) | PL125972B1 (cs) |
| PT (1) | PT69460A (cs) |
| SU (2) | SU1259962A3 (cs) |
| ZA (1) | ZA791702B (cs) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2823197A1 (de) * | 1978-05-24 | 1979-11-29 | Schering Ag | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| DE2856909A1 (de) * | 1978-12-28 | 1980-07-17 | Schering Ag | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| DE3025484A1 (de) * | 1980-07-03 | 1982-02-04 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| US4686231A (en) * | 1985-12-12 | 1987-08-11 | Smithkline Beckman Corporation | Inhibition of 5-lipoxygenase products |
| US4780470A (en) * | 1986-08-19 | 1988-10-25 | Smithkline Beckman Corporation | Inhibition of interleukin-1 by monocytes and/or macrophages |
| FI91754C (fi) * | 1986-12-02 | 1994-08-10 | Tanabe Seiyaku Co | Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi |
| US5593992A (en) * | 1993-07-16 | 1997-01-14 | Smithkline Beecham Corporation | Compounds |
| US5955480A (en) * | 1996-11-20 | 1999-09-21 | Merck & Co., Inc. | Triaryl substituted imidazoles, compositions containing such compounds and methods of use |
| US5965583A (en) * | 1997-04-24 | 1999-10-12 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted imidazoles useful in the treatment of inflammatory disease |
| JP2002515915A (ja) * | 1997-06-30 | 2002-05-28 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 炎症性疾患の治療で有用な２−置換イミダゾール類 |
| DE19842833B4 (de) * | 1998-09-18 | 2005-04-14 | Merckle Gmbh | 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung |
| DE10107683A1 (de) * | 2001-02-19 | 2002-08-29 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
| DE10238045A1 (de) * | 2002-08-20 | 2004-03-04 | Merckle Gmbh Chem.-Pharm. Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
| US8134029B2 (en) | 2002-09-16 | 2012-03-13 | Sunovion Pharmaceuticals Inc. | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine |
| SE0401653D0 (sv) * | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | New compounds |
| AU2006264317B2 (en) | 2005-07-06 | 2012-02-23 | Sunovion Pharmaceuticals Inc. | Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders |
| DK2013835T3 (en) | 2006-03-31 | 2015-12-14 | Sunovion Pharmaceuticals Inc | Preparation of chiral amides and AMINES |
| EP1894925A1 (en) * | 2006-08-24 | 2008-03-05 | Merckle Gmbh | Imidazole compounds having an antiinflammatory effect |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2981739A (en) * | 1958-01-27 | 1961-04-25 | Diamond Alkali Co | Certain alpha-haloaldehyde addition products of ethylenethioureas and process |
| US3714179A (en) * | 1970-09-08 | 1973-01-30 | Searle & Co | 1-alkyl-2-furfurylthioimidazoles and congeners |
| JPS5343958B2 (cs) * | 1972-07-29 | 1978-11-24 | ||
| SE428686B (sv) * | 1975-08-11 | 1983-07-18 | Du Pont | Forfarande for framstellning av antiinflammatoriskt aktiva imidazoler |
| DK16778A (da) * | 1977-02-09 | 1978-08-10 | Du Pont | Imidazolderivater deres anvendelser og fremstilling |
| US4159338A (en) * | 1977-02-09 | 1979-06-26 | E. I. Du Pont De Nemours And Company | Antiinflammatory-4,5-dicyclic-2-(substituted thio)-imidazoles and their corresponding sulfoxides and sulfones |
| LU77703A1 (de) * | 1977-07-07 | 1979-03-26 | Ciba Geigy Ag | Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen |
| DE2823197A1 (de) * | 1978-05-24 | 1979-11-29 | Schering Ag | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| US4308277A (en) * | 1978-08-10 | 1981-12-29 | Ciba-Geigy Corporation | 2,4,5-Trisubstituted imidazolines and pharmaceutical compositions containing same |
| US4175127A (en) * | 1978-09-27 | 1979-11-20 | Smithkline Corporation | Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles |
| DE2856909A1 (de) * | 1978-12-28 | 1980-07-17 | Schering Ag | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
-
1979
- 1979-03-30 EP EP79100962A patent/EP0004648B1/de not_active Expired
- 1979-03-30 DE DE7979100962T patent/DE2963572D1/de not_active Expired
- 1979-03-30 CY CY1302A patent/CY1302A/xx unknown
- 1979-04-06 GR GR58824A patent/GR71193B/el unknown
- 1979-04-06 PL PL1979214745A patent/PL125972B1/pl unknown
- 1979-04-06 PL PL1979226123A patent/PL125882B1/pl unknown
- 1979-04-09 DD DD79212098A patent/DD142712A5/de unknown
- 1979-04-09 FI FI791158A patent/FI65066C/fi not_active IP Right Cessation
- 1979-04-10 HU HU79CI1925A patent/HU182018B/hu unknown
- 1979-04-10 KR KR7901118A patent/KR820002314B1/ko not_active Expired
- 1979-04-10 DK DK148879A patent/DK148879A/da not_active IP Right Cessation
- 1979-04-10 IL IL57040A patent/IL57040A/xx unknown
- 1979-04-10 AU AU45994/79A patent/AU532402B2/en not_active Ceased
- 1979-04-10 NZ NZ190153A patent/NZ190153A/en unknown
- 1979-04-10 AT AT0266179A patent/AT376971B/de not_active IP Right Cessation
- 1979-04-10 ES ES479490A patent/ES479490A0/es active Granted
- 1979-04-10 CS CS792438A patent/CS220324B2/cs unknown
- 1979-04-10 PT PT69460A patent/PT69460A/pt unknown
- 1979-04-10 SU SU2747651A patent/SU1259962A3/ru active
- 1979-04-10 NO NO791228A patent/NO148926C/no unknown
- 1979-04-10 ZA ZA791702A patent/ZA791702B/xx unknown
- 1979-04-11 JP JP4311779A patent/JPS54135769A/ja active Granted
-
1980
- 1980-05-23 SU SU802925099A patent/SU991945A3/ru active
-
1981
- 1981-11-16 US US06/321,840 patent/US4461770A/en not_active Expired - Fee Related
-
1982
- 1982-09-16 ES ES515766A patent/ES8403877A1/es not_active Expired
- 1982-10-04 KR KR8204468A patent/KR820002315B1/ko not_active Expired
-
1983
- 1983-12-30 ES ES528581A patent/ES528581A0/es active Granted
- 1983-12-30 ES ES528580A patent/ES8504738A1/es not_active Expired
- 1983-12-30 ES ES528579A patent/ES528579A0/es active Granted
-
1984
- 1984-03-09 US US06/588,025 patent/US4608382A/en not_active Expired - Fee Related
- 1984-03-09 US US06/588,024 patent/US4584310A/en not_active Expired - Fee Related
-
1985
- 1985-11-07 HK HK872/85A patent/HK87285A/xx unknown
-
1986
- 1986-12-30 MY MY271/86A patent/MY8600271A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2964397D1 (en) | Process for the preparation of 4-pyridone-3-carboxylic acids, 1-cyclopropyl-4-pyridone-3-carboxylic acid derivatives and medicines containing them | |
| DE2960222D1 (en) | Phenoxyalkylcarboxylic-acid derivatives, process for their preparation and medicaments containing them | |
| ZA792937B (en) | Process for the preparation of spheroidally shaped products | |
| DE2962122D1 (en) | 17-alkylcarbonates of corticoids, process for their preparation and their use as medicines against dermatoses | |
| DE2962631D1 (en) | Process for the sterilization of pharmaceutical products | |
| MY8600271A (en) | Novel mercaptoimidazole derivatives process for their preparation, mercapto-imidazole derivatives for the treatment of inflammatory disorders, and pharmaceutical products containing them | |
| IL57662A (en) | Acyl-esters of carnitine,process for their preparation and pharmaceutical compositions comprising them | |
| PT71676B (en) | Process for the preparation of new derivatives of 1h-indolhaving pharmaceutical properties | |
| DE2960954D1 (en) | 1-aryloxy-3-nitratoalkylamino-2-propanols, process for their preparation and pharmaceutical compositions | |
| IL56944A (en) | Process for the preparation of cis-hexahydrodibenzopyranones and 3,4,5,6-tetrahydro-2h-1-benzoxocin derivatives | |
| DE3062981D1 (en) | Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives | |
| EP0007576A3 (en) | Esters of stilbene derivatives, process for their preparation, intermediate products and their preparation, use of the esters as insecticides | |
| DE2961983D1 (en) | Pyrrolidine-2-methanol derivatives, process for their preparation and medicaments containing them | |
| DE2964209D1 (en) | Spiro-furanohydantoin derivatives, process for their preparation and pharmaceutical compositions containing them | |
| PT73061B (en) | Process for the preparation of new derivatives of taurina and its pharmaceutical use | |
| IL65810A0 (en) | Substituted tryptamine derivatives of thienyloxypropanolamines,process for their preparation,pharmaceutical products based on these compounds and the use of these products | |
| GB2037185B (en) | Dielectric product and process for the preparation thereof | |
| ZA79271B (en) | 1-naphthyl-acetic acid derivatives,process for their preparation and their therapeutic applications | |
| IL57533A (en) | 17alpha-acetylene derivatives of androst-4-ene,process for preparing them and pharmaceutical compositions containing them | |
| PT72237A (en) | Process for the preparation of new pyrrolbenzotriazepines having pharmaceutical effect | |
| DE2961524D1 (en) | Glycofuranosyl-nitrosourea derivatives, process for their manufacture and their pharmaceutical preparations | |
| DE2960037D1 (en) | Isoquinolines, process for their preparation and their use for the preparation of medicines | |
| GB2033902B (en) | 1,6-naphthyridine derivatives process for the production thereof and pharmaceutical composition containing such derivatives | |
| ZA79365B (en) | Novel azathianaphthalene derivatives,process for their manufacture,pharmaceutical preparations containing them and their use | |
| IL60268A0 (en) | Process for the preparation of 3,3-dimethyl-cyclopropane-1,1,2-tricarboxylic acid derivatives,and -halogeno-nitriles as new intermediate products for this process and their preparation |